An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies

NCT02431260 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
69
Enrollment
INDUSTRY
Sponsor class

Stopped As of 31 JAN 2018, the study was terminated by the sponsor due to PK variability.

Conditions

Interventions

Sponsor

Incyte Corporation